Loading...
Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study
BACKGROUND: Glucocorticoids are the cornerstone treatment of polymyalgia rheumatica (PMR) but induce adverse events. OBJECTIVES: To evaluate the efficacy and safety of first-line tocilizumab in PMR. METHODS: In a prospective open-label study (ClinicalTrials.gov: NCT01713842), 20 glucocorticoid-free...
Na minha lista:
| Udgivet i: | Ann Rheum Dis |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMJ Publishing Group
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4975852/ https://ncbi.nlm.nih.gov/pubmed/26929219 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2015-208742 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|